文献速递造血干细胞移植与细胞治疗淋巴瘤

动态监测血浆EB病毒DNA载量可预测单倍体造血干细胞移植后淋巴细胞增殖性疾病的发生

[Dynamic monitoring of plasma Epstein-Barr Virus DNA load can predict the occurrence of lymphoproliferative disorders after haploidentical hematopoietic stem cell transplantation].
PubMed 文献 · Zhonghua Xue Ye Xue Za Zhi · 2023-01-01

该研究回顾性分析2016年1月至12月94例单倍体造血干细胞移植后EBV感染患者,其中20例(21.3%)发生PTLD。通过ROC曲线确定EBV-DNA载量≥41 850拷贝/ml(AUC=0.847)及EBV血症持续时间≥20.5 d(AUC=0.833)对PTLD有诊断意义。结论认为动态监测EBV载量及持续时间有助于提前预测PTLD发生并早期干预。

要点

  • 94例单倍体移植后EBV感染患者中20例(21.3%)发生PTLD,中位发生时间为移植后56(40-309)d。
  • 诊断PTLD时中位EBV-DNA载量为70 400(1 710-1 370 000)拷贝/ml,EBV血症中位持续23.5(4-490)d。
  • EBV-DNA载量≥41 850拷贝/ml对PTLD有诊断意义(AUC=0.847),敏感度0.611、特异度0.932。

核心结论

  • 动态监测单倍体造血干细胞移植后PTLD高危患者的EBV载量及关注其持续时间有重要临床意义,有助于临床提前预测PTLD的发生并早期采取干预措施。

研究设计与样本

  • 回顾性分析北京大学血液病研究所2016年1月至12月期间单倍体造血干细胞移植后合并EBV感染患者的相关数据,共纳入94例患者。
  • 通过构建ROC曲线计算约登指数寻找对PTLD有诊断意义的EBV-DNA载量及其持续时间的临界值。

主要发现

  • 94例患者中20例(21.3%)发生PTLD,诊断PTLD时中位EBV-DNA载量为70 400(1 710-1 370 000)拷贝/ml,EBV血症中位持续时间为23.5(4-490)d。
  • 二元logistic回归分析显示,PTLD组与非PTLD组间EBV-DNA最高载量及EBV血症持续时间差异均有统计学意义(P=0.018,P=0.001)。
  • EBV-DNA载量≥41 850拷贝/ml对PTLD有诊断意义(AUC=0.847),敏感度、特异度分别为0.611、0.932。
  • EBV血症持续时间≥20.5 d对PTLD有诊断意义(AUC=0.833),敏感度、特异度分别为0.778、0.795。

关键数值与推荐

  • EBV-DNA载量≥41 850拷贝/ml对PTLD有诊断意义(AUC=0.847),敏感度0.611、特异度0.932。
  • EBV血症持续时间≥20.5 d对PTLD有诊断意义(AUC=0.833),敏感度0.778、特异度0.795。

临床怎么用

  • 作者认为,动态监测单倍体造血干细胞移植后PTLD高危患者的EBV载量及关注其持续时间有重要临床意义,有助于临床提前预测PTLD的发生并早期采取干预措施。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To determine the optimal cutoff value of Epstein-Barr virus (EBV) DNA load that can assist in the diagnosis of post-transplant lymphoproliferative disease (PTLD) after haploidentical hematopoietic stem cell transplantation (haplo-HSCT) . Methods: The data of patients with EBV infection after haplo-HSCT from January to December 2016 were retrospectively analyzed. Through constructing the receiver operating characteristic (ROC) curve and calculating the Youden index to determine the cutoff value of EBV-DNA load and its duration of diagnostic significance for PTLD. Results: A total of 94 patients were included, of whom 20 (21.3% ) developed PTLD, with a median onset time of 56 (40-309) d after transplantation. The median EBV value at the time of diagnosis of PTLD was 70,400 (1,710-1,370,000) copies/ml, and the median duration of EBV viremia was 23.5 (4-490) d. Binary logistic regression was used to analyze the peak EBV-DNA load (the EBV-DNA load at the time of diagnosis in the PTLD group) and duration of EBV viremia between the PTLD and non-PTLD groups. The results showed that the difference between the two groups was statistically significant (P=0.018 and P=0.001) . The ROC curve was constructed to calculate the Youden index, and it was concluded that the EBV-DNA load ≥ 41 850 copies/ml after allogeneic hematopoietic stem cell transplantation had diagnostic significance for PTLD (AUC=0.847) , and the sensitivity and specificity were 0.611 and 0.932, respectively. The duration of EBV viremia of ≥20.5 d had diagnostic significance for PTLD (AUC=0.833) , with a sensitivity and specificity of 0.778 and 0.795, respectively. Conclusion: Dynamic monitoring of EBV load in high-risk patients with PTLD after haplo-HSCT and attention to its duration have important clinical significance, which can help clinically predict the occurrence of PTLD in advance and take early intervention measures. 目的: 寻找可以协助诊断单倍体造血干细胞移植(haplo-HSCT)后淋巴细胞增殖性疾病(PTLD)的EB病毒DNA(EBV-DNA)载量及其持续时间的最佳临界值。 方法: 回顾性分析北京大学血液病研究所2016年1月至12月期间haplo-HSCT后合并EBV感染患者的相关数据,通过构建ROC曲线计算约登指数寻找对PTLD有诊断意义的EBV-DNA载量及其持续时间的临界值。 结果: 共纳入94例患者,其中20例(21.3%)发生PTLD,诊断PTLD时中位EBV-DNA载量为70 400(1 710~1370 000)拷贝/ml,EBV血症中位持续时间为23.5(4~490)d。二元logistic回归分析显示,PTLD组与非PTLD组两组间EBV-DNA最高载量及EBV血症持续时间差异均有统计学意义(P=0.018,P=0.001)。构建ROC曲线计算约登指数,EBV-DNA载量≥41 850拷贝/ml对PTLD有诊断意义[曲线下面积(AUC)=0.847],敏感度、特异度分别为0.611、0.932;EBV血症持续时间≥20.5 d对PTLD有诊断意义(AUC=0.833),敏感度、特异度分别为0.778、0.795。 结论: 动态监测haplo-HSCT后PTLD高危患者的EBV载量及关注其持续时间有重要临床意义,有助于预测PTLD的发生并早期采取干预措施。.

来源:Zhonghua Xue Ye Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Chen J, Sun YQ, Xu LP, et al. [Dynamic monitoring of plasma Epstein-Barr Virus DNA load can predict the occurrence of lymphoproliferative disorders after haploidentical hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi. 2023. PMID: 37356996. doi:10.3760/cma.j.issn.0253-2727.2023.04.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。